Skip to main content
Contact Us
Subscribe
E-Edition
52°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Entertainment
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about GILD
Recent news which mentions GILD
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
Why Jim Cramer Believes Loves Berkshire Hathaway And Rivian
February 07, 2022
Tickers
BRK-B
GILD
GM
RIVN
Tags
Media
VZ
Jim Cramer
From
Benzinga
3 Biotech Stocks That Could Make You Richer in February (and Beyond)
February 05, 2022
Tickers
ACET
AMGN
AZN
GILD
Tags
Market News
AZN
ACET
From
Motley Fool
5 Biotech Stocks to Buy to Benefit From Biden’s New Cancer Cabinet
February 04, 2022
Tickers
BMY
GILD
LLY
MRK
Tags
NYSE:BMY,NYSE:LLY,NYSE:PFE,NYSE:MRK,NASDAQ:GILD,NASDAQ:VERU
LLY
VERU
From
InvestorPlace
COVID-19 treatments raked in billions of dollars in 2021. How will they do this year?
February 04, 2022
Tickers
GILD
GSK
LLY
MRK
Tags
VIR
GSK
PFE
From
MarketWatch
How Big Are Gilead's Latest COVID Wins?
February 03, 2022
Tickers
GILD
PFE
Tags
Recent Press Releases
PFE
GILD
From
Motley Fool
GSK To Get $1.25B As Settlement For HIV Treatment Drug Patent Row With Gilead
February 02, 2022
Tickers
GILD
GSK
PFE
Tags
Movers
Legal
Benzinga
From
Benzinga
The Daily Biotech Pulse: LogicBio Genome Editing Therapy Study Placed On Clinical Hold, Gilead Q4 Disappoints On Slowing Veklury Sales
February 02, 2022
Tickers
ABBV
ARWR
ATHX
AVIR
Tags
Top Stories
ABBV
LOGC
From
Benzinga
Gilead Q4 Earnings Highlights: Remdesivir Sales Fall 30%, Raises Dividend, FY22 EPS Below Estimates
February 02, 2022
Tickers
GILD
Tags
General
Health Care
Guidance
From
Benzinga
Gilead Sciences (GILD) Q4 2021 Earnings Call Transcript
February 02, 2022
Tickers
GILD
Tags
GILD
Market News
Recent Press Releases
From
Motley Fool
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 01, 2022
Tickers
AGRX
BFRI
CLSN
ENVB
Tags
IMMX
BZI/TFM
VKTX
From
Benzinga
Gilead earnings slammed by legal settlement, stock falls
February 01, 2022
Tickers
GILD
GSK
PFE
RCUS
Tags
PFE
RCUS
GSK
From
MarketWatch
Gilead Sciences: Q4 Earnings Insights
February 01, 2022
Tickers
GILD
Tags
Earnings
BZI/Recaps
Market News
From
Benzinga
Is AbbVie Stock a Buy Now?
February 01, 2022
Tickers
ABBV
GILD
NVS
SNY
Tags
Market News
NVS
GILD
From
Motley Fool
What This FDA News Could Mean for Pfizer
February 01, 2022
Tickers
GILD
LLY
MRK
PFE
Tags
GILD
MRK
REGN
From
Motley Fool
Attention Biotech Investors: Mark Your Calendar For These Key February PDUFA Dates
February 01, 2022
Tickers
AGIO
AMYT
ATXI
CTIC
Tags
General
AMYT
IMCR
From
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 31, 2022
Tickers
ALGN
BMY
CNC
CVS
Tags
Options
MRK
ALGN
From
Benzinga
How to Invest in Biotech When Deep Value Has no Discernible Meaning
January 31, 2022
Tickers
AMGN
BMY
GILD
Tags
BMY
GILD
Market News
From
Motley Fool
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
January 31, 2022
Tickers
ABBV
ABMD
AMLX
ARWR
Tags
SNY
CINC
RHHBY
From
Benzinga
Is Gilead Sciences Stock a Buy Now?
January 31, 2022
Tickers
GILD
Tags
Market News
GILD
Recent Press Releases
From
Motley Fool
3 Growth ETFs to Consider Buying During This Correction
January 29, 2022
Tickers
BNTX
CURLF
EDIT
GILD
Tags
OCGN
GTBIF
TCNNF
From
Motley Fool
What 5 Analyst Ratings Have To Say About Gilead Sciences
January 28, 2022
Tickers
GILD
Tags
Benzinga
GILD
Market News
From
Benzinga
The Daily Biotech Pulse: Gilead's Blood Cancer Studies Placed On Partial Clinical Hold, Immunocore Gets FDA Nod, NRx Touts Positive COVID-19 Data
January 26, 2022
Tickers
ABT
BMY
CUE
EW
Tags
Biotech
IMCR
General
From
Benzinga
FDA Puts Clinical Hold On Gilead's Magrolimab/Azacitidine Combo Trials In Blood Cancer Settings
January 26, 2022
Tickers
GILD
Tags
Benzinga
FDA
GILD
From
Benzinga
Why Sierra Oncology Stock Is On Fire Today
January 25, 2022
Tickers
GILD
SRRA
Tags
Recent Press Releases
Market News
SRRA
From
Motley Fool
FDA Rescinds Authorization For Regeneron, Eli Lilly COVID-19 Antibody Treatments: Here's Why
January 24, 2022
Tickers
GILD
LLY
MRK
PFE
Tags
GILD
Benzinga
LLY
From
Benzinga
A Peek Into The Markets: US Stock Futures Down Following Friday's Plunge
January 24, 2022
Tickers
ABBV
GILD
HAL
IBM
Tags
GILD
Eurozone
Earnings
From
Benzinga
FDA Approves Gilead's Remdesivir For Non-Hospitalized COVID-19 Patients At High Risk For Disease Progression
January 24, 2022
Tickers
GILD
Tags
GILD
FDA
Benzinga
From
Benzinga
Everest Boosts Covid Bet With New Licensing Deal Despite Crowded Field
January 20, 2022
Tickers
BNTX
GILD
LLY
MRK
Tags
GILD
Benzinga
LLY
From
Benzinga
South Africa study shows boosters failed to block omicron, bolstering case for face masks, distancing and hand washing
January 20, 2022
Tickers
BNTX
GILD
GSK
MRK
Tags
MRNA
UK:GSK
GILD
From
MarketWatch
We need a decisive pivot on COVID-19: Double down on treatments for those at high risk instead of boosters and tests for everyone
January 20, 2022
Tickers
GILD
MRK
PFE
Tags
PFE
MRK
GILD
From
MarketWatch
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.